These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17530776)

  • 1. The Rule of Five revisited: applying log D in place of log P in drug-likeness filters.
    Bhal SK; Kassam K; Peirson IG; Pearl GM
    Mol Pharm; 2007; 4(4):556-60. PubMed ID: 17530776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fraction Lipophilicity Index (FLI). A drug-like metric for orally administered ionizable drugs.
    Tsantili-Kakoulidou A; Demopoulos VJ
    SAR QSAR Environ Res; 2019 Sep; 30(9):643-653. PubMed ID: 31469319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive approaches to increase absorption of compounds during lead optimisation.
    Valko K; Butler J; Eddershaw P
    Expert Opin Drug Discov; 2013 Oct; 8(10):1225-38. PubMed ID: 23865945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
    Tetko IV; Poda GI
    J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.
    Camenisch G; Alsenz J; van de Waterbeemd H; Folkers G
    Eur J Pharm Sci; 1998 Oct; 6(4):317-24. PubMed ID: 9795088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR model for drug human oral bioavailability.
    Yoshida F; Topliss JG
    J Med Chem; 2000 Jun; 43(13):2575-85. PubMed ID: 10891117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.
    Wenlock MC; Barton P; Luker T
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3550-6. PubMed ID: 21601448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).
    Durairaj C; Shah JC; Senapati S; Kompella UB
    Pharm Res; 2009 May; 26(5):1236-60. PubMed ID: 18841448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
    Chen M; Borlak J; Tong W
    Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational prediction of formulation strategies for beyond-rule-of-5 compounds.
    Bergström CAS; Charman WN; Porter CJH
    Adv Drug Deliv Rev; 2016 Jun; 101():6-21. PubMed ID: 26928657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery.
    Fink T; Reymond JL
    J Chem Inf Model; 2007; 47(2):342-53. PubMed ID: 17260980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.
    Naylor MR; Ly AM; Handford MJ; Ramos DP; Pye CR; Furukawa A; Klein VG; Noland RP; Edmondson Q; Turmon AC; Hewitt WM; Schwochert J; Townsend CE; Kelly CN; Blanco MJ; Lokey RS
    J Med Chem; 2018 Dec; 61(24):11169-11182. PubMed ID: 30395703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ask the experts: past, present and future of the rule of five.
    Baell J; Congreve M; Leeson P; Abad-Zapatero C
    Future Med Chem; 2013 May; 5(7):745-52. PubMed ID: 23651089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the prediction of blood-brain partitioning from molecular structure.
    Lobell M; Molnár L; Keserü GM
    J Pharm Sci; 2003 Feb; 92(2):360-70. PubMed ID: 12532385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution.
    Henchoz Y; Bard B; Guillarme D; Carrupt PA; Veuthey JL; Martel S
    Anal Bioanal Chem; 2009 Jun; 394(3):707-29. PubMed ID: 19184676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of specific "drug-like property" rules for carboxylate-containing oral drug candidates.
    Böcker A; Bonneau PR; Hucke O; Jakalian A; Edwards PJ
    ChemMedChem; 2010 Dec; 5(12):2102-13. PubMed ID: 20979082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.